
Bayer Watch 63E
Bayer, the pharmaceutical group, is nearing deals to resolve 50,000 to 85,000 of 125,000 U.S. cancer lawsuits over the use of its Roundup weedkiller
Share this:
The settlements still need approval from the company’s supervisory board, in June.
Chris Loder, a U.S.-based spokesman for Bayer said “As we have said previously, the company will consider a resolution if it is financially reasonable and provides a process to resolve potential future litigation.”
From a technical perspective, the stock price has landed on a support at 55.3E (Lower Bollinger band + 50DMA) and is posting a rebound. The bullish gap opened above the 20DMA is a positive signal. However, the stock price remains stuck in trading range on a short term basis between 55.3E and 63E.
A breakout confirmation of 63E would confirm the bullish outlook with 68E as target.
Alternatively, a push below 55.3E would reinstate a bearish bias towards 50E.
Source: GAIN Capital, TradingView
The settlements still need approval from the company’s supervisory board, in June.
Chris Loder, a U.S.-based spokesman for Bayer said “As we have said previously, the company will consider a resolution if it is financially reasonable and provides a process to resolve potential future litigation.”
From a technical perspective, the stock price has landed on a support at 55.3E (Lower Bollinger band + 50DMA) and is posting a rebound. The bullish gap opened above the 20DMA is a positive signal. However, the stock price remains stuck in trading range on a short term basis between 55.3E and 63E.
A breakout confirmation of 63E would confirm the bullish outlook with 68E as target.
Alternatively, a push below 55.3E would reinstate a bearish bias towards 50E.
Source: GAIN Capital, TradingView
Related tags:
Latest market news
View more newsOpen an account in minutes
Experience award-winning platforms with fast and secure execution.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

Gold Price Short-term Outlook: XAU/USD Bears Face Critical Test at Yearly Lows 11 17 2026
Gold's decline is showing signs of exhaustion at major support, with a pivotal range break in focus ahead of the FOMC minutes.

British Pound Technical Outlook: GBP/USD Tests Pivotal Support—Breakdown Risk Rises 11 17 2026
Sterling bears are pressing critical support near the yearly lows, with the next reaction likely to determine whether the broader trading range survives.

US Dollar, Gold, Silver Outlook: 2026 Extremes and Key Levels to Watch
US Dollar, Gold, Silver Outlook: Major currency pairs and precious metals are testing 2026 extremes as markets price in a 25-basis-point Fed rate hike in December. However, stretched momentum indicators are bringing near-term reversal risks into focus.
StoneX Financial Ltd (trading as "FOREX.com") is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, FOREX.com does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date.
This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it. No opinion given in this material constitutes a recommendation by FOREX.com or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although FOREX.com is not specifically prevented from dealing before providing this material, FOREX.com does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. For further details see our full non-independent research disclaimer and quarterly summary.





